Publication:
Melioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigens

dc.contributor.authorMaude Cloutieren_US
dc.contributor.authorEmmanilo Delaren_US
dc.contributor.authorKevin Muruen_US
dc.contributor.authorSeynabou Ndongen_US
dc.contributor.authorRobert R. Hoyecken_US
dc.contributor.authorTaniya Kaewarpaien_US
dc.contributor.authorNarisara Chantratitaen_US
dc.contributor.authorMary N. Burtnicken_US
dc.contributor.authorPaul J. Bretten_US
dc.contributor.authorCharles Gauthieren_US
dc.contributor.otherINRS-Institut Armand Frappieren_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Nevada School of Medicineen_US
dc.date.accessioned2020-01-27T07:58:12Z
dc.date.available2020-01-27T07:58:12Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 The Royal Society of Chemistry. Melioidosis and glanders, respectively caused by the Gram-negative bacteria Burkholderia pseudomallei (Bp) and Burkholderia mallei (Bm), are considered as urgent public health issues in developing countries and potential bioterrorism agents. Bp and Bm lipopolysaccharides (LPS) have been identified as attractive vaccine candidates for the development of prophylactic measures against melioidosis and glanders. Bp and Bm express structurally similar LPSs wherein the O-antigen (OAg) portion consists of a heteropolymer whose repeating unit is a disaccharide composed of d-glucose and 6-deoxy-l-talose residues, the latter being diversely acetylated and methylated. Herein we report the synthesis of two tetrasaccharides mimicking the main substitution epitopes of Bp and Bm LPS OAgs. The assembly of the tetrasaccharides was achieved using a sequential glycosylation strategy while relying on the late-stage epimerization of the inner rhamnose into a 6-deoxy-l-talose residue. We show that these synthetic compounds strongly react with culture-confirmed Thai melioidosis patient serum and closely mimic the antigenicity of native Bp OAg. Our results suggest that these tetrasaccharides could be suitable candidates for the development of vaccines and/or diagnostic tools against melioidosis and glanders.en_US
dc.identifier.citationOrganic and Biomolecular Chemistry. Vol.17, No.39 (2019), 8878-8901en_US
dc.identifier.doi10.1039/c9ob01711aen_US
dc.identifier.issn14770520en_US
dc.identifier.other2-s2.0-85073124963en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50390
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073124963&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.titleMelioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigensen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073124963&origin=inwarden_US

Files

Collections